Skip to main content

OncoGenome Sciences Inks $15.4M First Round

OncoGenome Sciences of Liege, Belgium, today announced a $15.4 million first-round funding led by Brank Brussels Lambert and a syndicate of European investors.

 

OncoGenome, founded in 2002 by Herman Spolders, a former vice president of business development and operations at Virco and headquartered at the medical school of the University of Liege, Belgium, is developing genomics-based diagnostic tests for cancer. The company has a US facility in Durham, NC.

 

Participating in the funder were PolyTechnos Venture-Partners of Munich, Germany; Life Sciences Partners of Amsterdam, Netherlands; and Belgium-based economic development investors: Technowal of Liege; Meusinvest of Liege; and SIBL, also of Liege, OncoGenome said in a statement.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.